Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen Stock Dives
Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.
Amgen stock was dropping sharply Tuesday after releasing what looked like positive data from a Phase 2 study for its experimental monthly weight-loss shot MariTide.Overweight or obese patients on MariTide lost 20% of their body weight on average,
Amgen's weight-loss drug fails to impress in study; shares plunge
Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 people who were overweight or obese, the company said on Tuesday.
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Shares of Amgen (NASDAQ: AMGN) recently ticked lower despite a very positive-sounding press release regarding its weight management candidate. According to the giant drugmaker, treatment with an anti-obesity candidate called MariTide helped patients reduce their weight by up to 20% after 52 weeks.
12h
on MSN
Amgen Obesity Drug More Effective Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
2d
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and ...
1d
Amgen price target lowered to $330 from $360 at RBC Capital
RBC Capital analyst Gregory Renza lowered the firm’s price target on Amgen (AMGN) to $330 from $360 and keeps an Outperform rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'City under the ice'
Mass arrests at parade
Wins reelection after recount
MD prison inmate killed
Boise State withdraws
Cybertruck crash kills 3
Asthma attack treatment
One-month doping ban
AU passes social media ban
Habitat protections plan
Meets Trump at Mar-a-Lago
Concedes in CA House race
UKR energy sector attacked
Costco recalls eggs
Abortions fell 2% in 2022
Court upholds TX razor wire
Capitol Hill visit on Dec 5
Travel advisory downgraded
Bail denied by third judge
Settles harassment lawsuit
Thanksgiving in space
Uber faces FTC probe
Menendez seeks new trial
Ohtani seeks baseball cards
Jan. 6 coverage suit tossed
China probes top official
Residents sue Givaudan
Retires after 14 seasons
NM man awarded $412M+
Stowaway found on flight
Feedback